This webinar will be hosted live and available on-demand.
Wednesday, July 22nd, 2026
5:00 - 6:00 PM CEST
Synthetic route design remains a major challenge in medicinal chemistry and small-molecule research, where chemists must balance feasibility, efficiency, scalability, and innovation while advancing discovery programs under increasing time constraints. Evaluating alternative synthetic pathways and assessing route accessibility early in development can significantly influence downstream experimental success and resource allocation.
In this webinar, brought to you by Merck KGaA, Darmstadt, Germany, Ewa Gajewska, head of product management at Merck KGaA, Darmstadt, Germany, will discuss how computer-assisted retrosynthesis software supports synthetic route planning in modern chemistry workflows. The session will examine how retrosynthesis platforms help researchers explore alternative disconnection strategies, evaluate route feasibility, and identify pathways using commercially available starting materials. The discussion will also highlight how digital synthesis planning tools support medicinal chemistry, drug discovery, and broader small-molecule research applications.
Topics to be covered
- Principles of computer-assisted retrosynthesis and route planning
- Strategies for evaluating synthetic feasibility during early discovery
- Approaches for exploring alternative synthetic pathways
- Applications of retrosynthesis software in medicinal chemistry workflows
- Considerations for integrating digital synthesis planning into research environments
 | Ewa Gajewska |
Sponsored by:
